Filing Details

Accession Number:
0001179110-12-014335
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-20 16:50:37
Reporting Period:
2012-09-18
Filing Date:
2012-09-20
Accepted Time:
2012-09-20 16:50:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
856982 Merit Medical Systems Inc MMSI Surgical & Medical Instruments & Apparatus (3841) 870447695
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901534 P Fred Lampropoulos 1600 W Merit Parkway
South Jordan UT 84095
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Disposition 2012-09-18 33,055 $15.09 1,011,392 No 4 S Direct
Common Stock, No Par Value Disposition 2012-09-19 34,670 $15.05 976,722 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, No Par Value 85,044 Indirect By 401(k) Plan
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Non-qualified stock options (right to buy) $8.38 2003-05-22 2013-05-22 33,334 33,334 Direct
Common Stock Non-qualified stock options (right to buy) $17.34 2004-12-13 2013-12-13 35,000 35,000 Direct
Common Stock Non-qualified stock options (right to buy) $17.34 2003-12-13 2013-12-13 18,750 18,750 Direct
Common Stock Non-qualified stock options (right to buy) $11.05 2004-06-10 2014-06-10 18,750 18,750 Direct
Common Stock Non-qualified stock options (right to buy) $11.05 2004-06-10 2014-06-10 15,000 15,000 Direct
Common Stock Non-qualified stock options (right to buy) $12.02 2004-12-18 2014-12-18 50,000 50,000 Direct
Common Stock Non-qualified stock options (right to buy) $11.41 2005-05-25 2015-05-25 18,750 18,750 Direct
Common Stock Non-qualified stock options (right to buy) $14.39 2005-07-15 2015-07-15 93,750 93,750 Direct
Common Stock Non-qualified stock options (right to buy) $9.71 2005-12-28 2015-12-28 50,000 50,000 Direct
Common Stock Non-qualified stock options (right to buy) $9.22 2007-05-25 2013-05-25 18,750 18,750 Direct
Common Stock Non-qualified stock options (right to buy) $9.70 2008-06-27 2014-06-27 50,000 50,000 Direct
Common Stock Non-qualified stock options (right to buy) $9.70 2008-06-27 2014-06-27 18,750 18,750 Direct
Common Stock Non-qualified stock options (right to buy) $11.53 2009-05-21 2015-05-21 68,750 68,750 Direct
Common Stock Non-qualified stock options (right to buy) $13.82 2010-09-26 2016-09-26 25,000 25,000 Direct
Common Stock Non-qualified stock options (right to buy) $13.75 2012-08-11 2018-08-11 120,000 120,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2013-05-22 33,334 33,334 Direct
2013-12-13 35,000 35,000 Direct
2013-12-13 18,750 18,750 Direct
2014-06-10 18,750 18,750 Direct
2014-06-10 15,000 15,000 Direct
2014-12-18 50,000 50,000 Direct
2015-05-25 18,750 18,750 Direct
2015-07-15 93,750 93,750 Direct
2015-12-28 50,000 50,000 Direct
2013-05-25 18,750 18,750 Direct
2014-06-27 50,000 50,000 Direct
2014-06-27 18,750 18,750 Direct
2015-05-21 68,750 68,750 Direct
2016-09-26 25,000 25,000 Direct
2018-08-11 120,000 120,000 Direct
Footnotes
  1. Represents plan holdings as of 9/13/2012.
  2. Becomes exercisable in equal annual installments of 20% commencing 12/13/2004.
  3. Becomes exercisable in equal annual installments of 33.33% commencing 5/25/2007.
  4. Becomes exercisable in equal annual installments of 20% commencing 6/27/2008.
  5. Becomes exercisable in equal annual installments of 20% commencing 5/21/2009.
  6. Becomes exercisable in equal annual installments of 20% commencing 9/26/2010.
  7. Becomes exercisable in equal annual installments of 20% commencing 8/11/2012.
  8. The price reported in the second line of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.04 to $15.16, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  9. The price reported in the third line of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.03 to $15.05, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.